TYK2 inhibitors and uses thereof
TW202639122APending Publication Date: 2026-10-01ALUMIS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114149274
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-04
- Filing Date
- 2025-12-15
- Publication Date
- 2026-10-01
Smart Images
Figure TWG2TA001078811_001 
Figure TWG2TA001078811_002 
Figure TWG2TA001078811_003
Abstract
Described herein are methods and compositions, for example a fixed dose oral composition, for treating a TYK2-mediated neuroinflammatory disease or disorder, and / or a TYK2-mediated neurodegenerative disease or disorder. In some embodiments, the TYK2-mediated disorder neuroinflammatory disease is, for example, multiple sclerosis.
Need to check novelty before this filing date? Find Prior Art